Cyclosporine A

Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy

M. X. Li, Yu, Y. W., Zhang, Z. Y., Zhao, H. D., and Xiao, F. L., “Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy”, vol. 14, pp. 2665-2673, 2015.

This study aimed to investigate the effects of administration of low-dose cyclosporine A (CsA) alone and the combination of low-dose CsA and a low-dose hormone for the treatment of elderly patients with membranous nephropathy. We divided 27 patients into two groups as follows: low-dose CsA group (group A) and the group receiving a combination of a low-dose hormone and low-dose CsA (group B). The treatment and follow-up times were ≥6 months.

Changes in peripheral blood Th1 and Th2 cells in rat liver transplantation under different immune statuses

Z. - L. Yang, Cheng, K., Sun, H. G., Zou, W. W., and Wu, M. M., “Changes in peripheral blood Th1 and Th2 cells in rat liver transplantation under different immune statuses”, vol. 12, pp. 6939-6946, 2013.

In this study, early expressions of peripheral blood Th1 and Th2 cells were documented following rat liver transplantation and related to immune status. Rats were divided into 3 groups: group A (control): syngeneic transplantation (Brown Norway (BN) → BN); group B: allogeneic transplantation + cyclosporine A (CsA); group C: allogeneic transplantation (Lewis → BN).

Subscribe to Cyclosporine A